Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Neurochem Res ; 29(11): 2125-34, 2004 Nov.
Article in English | MEDLINE | ID: mdl-15662847

ABSTRACT

Sodium butyrate (NaBt), a histone deacetylase inhibitor, can cause apoptosis in a number of cancer cells. However, the mechanism of this action is poorly understood. Increased intracellular [Ca(2+)] level has been suggested as a likely mechanism, but there is little corroborating data. In this report we provide evidence that NaBt-treated MSN neuroblastoma cells undergo massive apoptosis in the presence of serum and regardless of external or internal [Ca(2+)] levels. Presented data suggest that apoptotic effect of NaBt is both time- and dose-dependent (LD50 1 mM); and that, presence of serum or cAMP, a second messenger molecule that modulates the apoptotic program in a wide variety of cells could not circumvent the apoptotic effect of NaBt. Our findings suggest that NaBt-induced apoptosis in MSN neuroblastoma cells occurs via a pathway that is independent of Ca(2+) flux, intracellular [Ca(2+)] or cAMP levels. Further, we also present data that exclude a role for PKC or histones acetylation.


Subject(s)
Apoptosis/drug effects , Brain Neoplasms/pathology , Butyrates/pharmacology , Calcium Signaling/physiology , Neuroblastoma/pathology , Bucladesine/pharmacology , Calcium/metabolism , Calcium/pharmacology , Calcium Signaling/drug effects , Cell Line, Tumor , DNA Fragmentation , Humans , Phosphodiesterase Inhibitors/pharmacology , Tetrazolium Salts , Theophylline/pharmacology , Thiazoles
SELECTION OF CITATIONS
SEARCH DETAIL
...